0001864531 false 0001864531 2022-10-19 2022-10-19 0001864531 dhacu:UnitsEachConsistingOfOneShareOfCommonStockAndOneRedeemableWarrantMember 2022-10-19 2022-10-19 0001864531 us-gaap:CommonStockMember 2022-10-19 2022-10-19 0001864531 dhacu:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtAnExercisePriceOfDollar11.50Member 2022-10-19 2022-10-19 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

United States

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 8-K

 

Current Report

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

October 19, 2022

Date of Report (Date of earliest event reported)

 

Digital Health Acquisition Corp.

(Exact Name of Registrant as Specified in its Charter)

 

Delaware   001-41015   86-2970927

(State or other jurisdiction of

incorporation)

 

   (Commission File Number)   (I.R.S. Employer Identification No.)

980 N Federal Hwy #304

Boca Raton, FL

  33432
(Address of Principal Executive Offices)   (Zip Code)
             

Registrant’s telephone number, including area code: (561) 672-7068

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol   Name of each exchange on which registered
Units, each consisting of one share of Common Stock and one Redeemable Warrant   DHACU   The Nasdaq Global Market
         
Common Stock, par value $0.0001 per share   DHAC   The Nasdaq Global Market
         
Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50   DHACW   The Nasdaq Global Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On October 19, 2022, Brent Willis notified Digital Health Acquisition Corp. (the "Company") of his resignation from the board of directors effective as of such date. Mr. Willis's decision to resign was not the result of any dispute or disagreement with the Company on any matter relating to the Company's operation, policies (including accounting or financial policies) or practices.

 

On October 19, 2022, the board of directors of the Company appointed Kevin Lowdermilk as a director. Mr. Lowdermilk will receive the compensation for non-employee directors as described in the Company's Annual Report on Form 10-K for the fiscal year ended December 30, 2021. There are no arrangements or understandings between Mr. Lowdermilk and any other person pursuant to which he was appointed to serve on the board and Mr. Lowdermilk does not have a direct or indirect material interest in any "related party" transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K. There are no family relationships between Mr. Lowdermilk and any director or executive officer of the Company.

 

The board of directors also appointed Mr. Lowdermilk to the audit committee, the nominating committee and the compensation committee of the board.

 

 

 

  

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: October 19, 2022  
   
DIGITAL HEALTH ACQUISITION CORP.  
   
By: /s/ Scott Wolf  
Name: Scott Wolf  
Title: Chief Executive Officer and Chairman  

 

 

 

Digital Health Acquisition (NASDAQ:DHAC)
Historical Stock Chart
From Feb 2025 to Mar 2025 Click Here for more Digital Health Acquisition Charts.
Digital Health Acquisition (NASDAQ:DHAC)
Historical Stock Chart
From Mar 2024 to Mar 2025 Click Here for more Digital Health Acquisition Charts.